
Gestalt Diagnostics is a healthcare technology company specializing in digital pathology solutions that transform anatomic pathology laboratories from traditional glass slides and microscopes to automated, electronic digital workflows. Their flagship product, PathFlow®, is built on a radiology workflow engine and is designed to improve the speed and accuracy of disease diagnosis, supporting over 13 million reads per year. The company offers a suite of products including PathFlow®, Health Data Cloud, AI Custom Solutions, AI Requisition Engine, and LIS Archive & Migration, focusing on interoperability, security, and workflow streamlining for health systems, laboratories, and hospitals. Gestalt has formed key partnerships with AI and scanner vendors and has received regulatory approvals including CE-IVD marks and multiple patents. Their solutions are used by notable clients such as BioReference Laboratories, Yale University, and CellNetix. The company emphasizes quality, innovation, and customer experience, positioning itself as a leader in digital pathology workflow solutions with significant traction and industry recognition.

Gestalt Diagnostics is a healthcare technology company specializing in digital pathology solutions that transform anatomic pathology laboratories from traditional glass slides and microscopes to automated, electronic digital workflows. Their flagship product, PathFlow®, is built on a radiology workflow engine and is designed to improve the speed and accuracy of disease diagnosis, supporting over 13 million reads per year. The company offers a suite of products including PathFlow®, Health Data Cloud, AI Custom Solutions, AI Requisition Engine, and LIS Archive & Migration, focusing on interoperability, security, and workflow streamlining for health systems, laboratories, and hospitals. Gestalt has formed key partnerships with AI and scanner vendors and has received regulatory approvals including CE-IVD marks and multiple patents. Their solutions are used by notable clients such as BioReference Laboratories, Yale University, and CellNetix. The company emphasizes quality, innovation, and customer experience, positioning itself as a leader in digital pathology workflow solutions with significant traction and industry recognition.
Headquarters: Spokane, Washington
Founded: 2017
Flagship product: PathFlow® digital pathology platform (CE‑IVD certified)
2025 financing: $7.5M Series A led by Cowles Ventures (Apr 28, 2025)
Employee count: 35
Digital pathology workflow automation, image and case management, AI-enabled diagnostic workflows, and interoperability with EHR/LIS systems.
2017
Healthcare technology; digital pathology
$7.5M
Round included TVF Funds, Inland Imaging Investments, KickStart Funds and angel investors.
Growth capital / private credit financing.
“Raised institutional Series A led by Cowles Ventures and prior growth capital from Sun Mountain Private Credit; investors include regional funds and angel participation.”